Hunan Er-Kang Pharmaceutical Co (SZSE:300267) 3-Year Dividend Growth Rate : 0.00% (As of Mar. 2025)

View and export this data going back to 2011. Start your Free Trial

What is Hunan Er-Kang Pharmaceutical Co 3-Year Dividend Growth Rate?

Hunan Er-Kang Pharmaceutical Co's Dividends per Share for the three months ended in Mar. 2025 was ¥0.00.

The historical rank and industry rank for Hunan Er-Kang Pharmaceutical Co's 3-Year Dividend Growth Rate or its related term are showing as below:

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Hunan Er-Kang Pharmaceutical Co was 56.70% per year. The lowest was -41.50% per year. And the median was 4.75% per year.

SZSE:300267's 3-Year Dividend Growth Rate is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 11.3
* Ranked among companies with meaningful 3-Year Dividend Growth Rate only.

During the past 12 months, Hunan Er-Kang Pharmaceutical Co's average Dividends Per Share Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Hunan Er-Kang Pharmaceutical Co's Dividend Payout Ratio for the three months ended in Mar. 2025 was 0.00. As of today, Hunan Er-Kang Pharmaceutical Co's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Hunan Er-Kang Pharmaceutical Co's 3-Year Dividend Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Hunan Er-Kang Pharmaceutical Co's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hunan Er-Kang Pharmaceutical Co's 3-Year Dividend Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hunan Er-Kang Pharmaceutical Co's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Hunan Er-Kang Pharmaceutical Co's 3-Year Dividend Growth Rate falls into.

Save Embed

;

Save Embed

;

Hunan Er-Kang Pharmaceutical Co 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Hunan Er-Kang Pharmaceutical Co (SZSE:300267) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Hunan Er-Kang Pharmaceutical Co's Dividend Payout Ratio for the quarter that ended in Mar. 2025 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2025 )	/	EPS without NRI (Q: Mar. 2025 )
	=	0	/	0.011
	=	0.00

During the past 13 years, the highest Dividend Payout Ratio of Hunan Er-Kang Pharmaceutical Co was 0.25. The lowest was 0.04. And the median was 0.12.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

During the past 13 years, the highest Dividend Yield of Hunan Er-Kang Pharmaceutical Co was 1.59%. The lowest was 0.00%. And the median was 0.35%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hunan Er-Kang Pharmaceutical Co 3-Year Dividend Growth Rate Related Terms>

Hunan Er-Kang Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Er-Kang Pharmaceutical Co Ltd (SZSE:300267) » Definitions » 3-Year Dividend Growth Rate

Traded in Other Exchanges

N/A

Address

Kangping Road 167, National Economic and Technological Development Zone, Liuyang Changsha, Hunan, CHN, 410331

Website

http://www.hnerkang.com

Hunan Er-Kang Pharmaceutical Co Ltd develops, produces and sells pharmaceutical products in China. The company's main products include pharmaceutical excipients and antibiotics. It offers pharmaceutical excipients, APIs and finished drug products. The pharmaceutical excipients include products such as glycerol, ethanol pharmaceutically, acceptable propylene glycol, sodium hydroxide, and pharmaceutically acceptable sugar. The company's finished drugs primarily include sulbenicillin sodium for injection and compound liquorice tablets. Its APIs include glycerin, dilute hydrochloric acid, dihydroxypropyl theophylline, sulbenicillin sodium, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol. Geographically, all the activities are carried out through China.

Executives

Shuai Fang Wen	Director
Wang Jun Wen	Independent director
Zuo Tian Fang	Independent director
Qi Yang	Supervisors
Li Yi Guo	Supervisors
Chen Wen Xian	Supervisors
Wang Xiang Feng	Directors, executives
Liu Ai Jun	Directors, executives
Luo Lang	Directors, executives
Fan Yi	Securities Affairs Representative
Yang Hai Ming	Directors, executives
Shuai You Wen	Director
Shuai Rui Wen	Director
Gao Zhen Ya	Executives
Cao Zai Yun	Director

Hunan Er-Kang Pharmaceutical Co Headlines

No Headlines